Bid of $6.5B for Athenahealth might be ploy to lure other bidders, including Anthem
Shares in Athenahealth Inc. surged the most since 2016 after activist investor Elliott Management Corp. bid to acquire the medical company for $160 a share.
Health Care & Life Sciences
Articles
Major health initiative targets 3 Indianapolis neighborhoods with high diabetes rates
A five-year, $7 million program is led and supported by a coalition of local health institutions, including Eli Lilly and Co., Fairbanks School of Public Health and Eskenazi Health. It is based on a model that Lilly has used in other countries.
Private equity firms mull bids for Eli Lilly’s Elanco unit
The Indianapolis pharmaceutical giant is evaluating whether to keep the division, which makes animal-health products, or sell it or take it public. An analyst said it might fetch $16 billion.
Eli Lilly hikes forecast after better-than-expected first quarter
Indianapolis-based Eli Lilly and Co. on Tuesday reported quarterly revenue and adjusted earnings that exceeded analyst forecasts.
Groups sue over new state law that toughens abortion rules
The plaintiffs—Planned Parenthood of Indiana and Kentucky, the American Civil Liberties Union and the ACLU of Indiana—called the measure "a cruel intimidation tactic."
Indiana gets another $11M to combat heroin, opioid abuse
The Health and Human Services funding is among $485 million recently awarded nationwide to combat heroin and opioid abuse.
Cigna-Express Scripts deal to face Justice Department review
Cigna Corp. confirmed that its proposed $54 billion acquisition of Express Scripts Holding Co. will be reviewed by the U.S. Department of Justice, which has raised the bar for approving deals that don’t combine direct competitors.
Americans filling far fewer opioid prescriptions, new report says
The number of prescriptions for opioid painkillers filled in the United States fell dramatically last year, showing their biggest drop in 25 years.
Mainstreet retools, says old strategy ‘broke down’
For more than a decade, Zeke Turner built scores of senior-care facilities. But in the past year, Mainstreet has been reeling from an unexpected slowdown in sales of its properties.
St. Vincent rethinks how to deliver care; struggling parent cuts costs
Jonathan Nalli has a message for his 16,000 employees at St. Vincent Health: Get ready for more transformation and disruption.
Local health care software firm raises $7 million in capital
Indianapolis-based Hc1.com Inc., which sells customer-management software to health care enterprises, has raised three sizable rounds of capital in four years.
Anthem agrees to $1.6M settlement over autism therapy
Insurance company Anthem Inc. has agreed to settle a federal lawsuit filed by Indiana parents who were denied coverage for therapy for their children with autism.
Rare loss for Big Pharma will cost industry billions
Drugmakers will have to offer a much more generous discount to Medicare beneficiaries who fall into the so-called donut hole coverage gap.
Indiana group to create app to teach doctors about opioids
The Richard M. Fairbanks Foundation awarded $230,000 to the Indiana State Medical Association this week to develop the app and an accompanying podcast.
Transforming Methodist: IU Health figuring out what to demolish, save
By the end of the year, officials expect to unveil its master plan to remake the state’s largest hospital—currently an amalgamation of ancient health care amenities and modern facilities.
Lilly signs licensing deal with biotech startup for diabetes drug
Under the agreement, Lilly will pay Sigilon Therapeutics up to $410 million if the technology hits certain milestones.
Anthem members face bigger bills at local micro-hospitals
The Indianapolis-based insurer is telling members that those small, freestanding hospitals are out of its network and could be much costlier to use.
High court asked to take case that could determine size of eye drops
What most people see as an annoyance, some prescription drop users say is grounds for a lawsuit.
Former exec sues Mainstreet, says developer failed to pay him $630,989
Ned Rule, former managing director of investments, claims the Carmel-based developer terminated him without cause to save money during a financial downturn, violating his employment contract.
Lilly revives proposals that would lower takeover barriers
The company’s board is asking shareholders to support two corporate-governance proposals, including one that would eliminate a requirement that buyout bids garner at least 80 percent shareholder approval.